Jennison Associates’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-621,679
| Closed | -$19.1M | – | 615 |
|
|
2023
Q3 | $19.1M | Sell |
621,679
-343,751
| -36% | -$10.5M | 0.02% | 320 |
|
|
2023
Q2 | $38.7M | Buy |
965,430
+139,593
| +17% | +$5.59M | 0.03% | 224 |
|
|
2023
Q1 | $33.7M | Sell |
825,837
-9,468
| -1% | -$386K | 0.03% | 249 |
|
|
2022
Q4 | $32.3M | Buy |
835,305
+38,254
| +5% | +$1.48M | 0.03% | 260 |
|
|
2022
Q3 | $42.4M | Buy |
797,051
+382,680
| +92% | +$20.4M | 0.04% | 195 |
|
|
2022
Q2 | $24.2M | Buy |
+414,371
| New | +$24.2M | 0.02% | 289 |
|
|
2018
Q2 | – | Sell |
-515,132
| Closed | -$16M | – | 694 |
|
|
2018
Q1 | $16M | Buy |
+515,132
| New | +$16M | 0.02% | 417 |
|
|
2016
Q2 | – | Sell |
-954,110
| Closed | -$50.5M | – | 643 |
|
|
2016
Q1 | $50.5M | Buy |
954,110
+12,123
| +1% | +$642K | 0.05% | 274 |
|
|
2015
Q4 | $72.3M | Sell |
941,987
-11,889
| -1% | -$913K | 0.07% | 225 |
|
|
2015
Q3 | $39.2M | Sell |
953,876
-718,732
| -43% | -$29.5M | 0.04% | 345 |
|
|
2015
Q2 | $118M | Sell |
1,672,608
-1,174,059
| -41% | -$83M | 0.11% | 176 |
|
|
2015
Q1 | $253M | Sell |
2,846,667
-11,581
| -0.4% | -$1.03M | 0.23% | 86 |
|
|
2014
Q4 | $253M | Buy |
2,858,248
+598,516
| +26% | +$53.1M | 0.24% | 87 |
|
|
2014
Q3 | $219M | Sell |
2,259,732
-270,178
| -11% | -$26.2M | 0.2% | 92 |
|
|
2014
Q2 | $232M | Sell |
2,529,910
-102,906
| -4% | -$9.45M | 0.21% | 102 |
|
|
2014
Q1 | $184M | Sell |
2,632,816
-142,172
| -5% | -$9.95M | 0.18% | 117 |
|
|
2013
Q4 | $160M | Buy |
2,774,988
+156,574
| +6% | +$9M | 0.16% | 131 |
|
|
2013
Q3 | $126M | Buy |
2,618,414
+17,040
| +0.7% | +$819K | 0.13% | 153 |
|
|
2013
Q2 | $75.4M | Buy |
+2,601,374
| New | +$75.4M | 0.08% | 220 |
|